Can Epidermal Growth Factor Receptor Improve the Postoperative Survivorship for Inoperable Non-small Cell Lung Cancer With Spinal Metastasis ?

Taipei Veterans General Hospital

Status: Completed

Conditions: Is Targeted Therapy Increasing Survival Inoperable Nonsmall Cell Lung Cancer With Spinal Metastasis ?

Treatments: Drug: Gefitinib

Study type: Observational

Funder types: Other

Identifiers

NCT02740894

2016-02-006CC

Details and patient eligibility

About

Not significantly increased survival in T/T

Enrollment: 100 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• NSCLC with spinal metastasis

Exclusion criteria

• brain metastasis and expected survival < 3 months

Trial design

100 participants in 2 patient groups

targeted therapy

Description:

according to national healthy policy, targeted therapy is the optional therapy

Treatment:

Drug: Gefitinib

traditional chemotherapy

Description:

according to national healthy policy, chemotherapy is the first line treatment.

Treatment:

Drug: Gefitinib